Search - tctmd.com

Displaying 281 - 300 of 2406

Sort: Relevancy | Date

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

Spontaneous Left Main Coronary Artery Dissection Post Percutaneous Coronary Intervention of Left Anterior Descending Artery

Presentation Fellows 2024

Breaking Bad: A Left Main Coronary Artery Dissection Saga Post Percutaneous Coronary Intervention

Presenter: Samarthkumar Thakkar

April 14, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

QCA an Alternative to IVUS? GUIDE-DES Trial Hints at the Possibility

Caitlin E. Cox

March 20, 2024

Presentation THT 2024

Estimating the Effect of Mechanical Circulatory Support on Mortality, Complications, and Readmission Rates in Patients Admitted with ST-Elevation Myocardial Infarction with Cardiogenic Shock who underwent Percutaneous Coronary Intervention

Presenter: Debapria Das

March 05, 2024

Presentation THT Abstracts 2024

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Presenter: Kannu Bansal

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Opinion Off Script

Passion, Persistence, and Generosity: Remembering Alain Cribier

Martin B. Leon, MD

February 27, 2024

News Daily News

New ACC Registry Aims to Track Outcomes at Ambulatory Centers

Shelley Wood

February 16, 2024

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Caitlin E. Cox

February 09, 2024

Presentation CTO 2024

Using Platelet Function Testing to Guide Medical Management Following Complex Percutaneous Coronary Intervention in Patients Requiring Therapeutic Anticoagulation

Presenter: Daniel J. Snyder

February 03, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Comparative Outcomes of Percutaneous Coronary Interventions in Patients with Chronic Total Occlusions: The Impact of Active Cancer

Presenter: Motisola Mutema

February 02, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention with Impella CP versus Impella 5.5

Presenter: Samip Vasaiwala

February 02, 2024

Advertisement

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Breaking Bad: A Left Main Coronary Artery Dissection Saga Post Percutaneous Coronary Intervention

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

What’s Going to Be Hot at ACC 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

QCA an Alternative to IVUS? GUIDE-DES Trial Hints at the Possibility

Estimating the Effect of Mechanical Circulatory Support on Mortality, Complications, and Readmission Rates in Patients Admitted with ST-Elevation Myocardial Infarction with Cardiogenic Shock who underwent Percutaneous Coronary Intervention

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Passion, Persistence, and Generosity: Remembering Alain Cribier

New ACC Registry Aims to Track Outcomes at Ambulatory Centers

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Using Platelet Function Testing to Guide Medical Management Following Complex Percutaneous Coronary Intervention in Patients Requiring Therapeutic Anticoagulation

Comparative Outcomes of Percutaneous Coronary Interventions in Patients with Chronic Total Occlusions: The Impact of Active Cancer

Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention with Impella CP versus Impella 5.5

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content